Subacute necrotising encephalomyelopathy (Leigh's disease; Leigh syndrome)

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 4, 2015, Pages 363-365

  Leigh, P N ^a,b   Al Sarraj, S ^c   DiMauro, S ^d  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; ERYTHROCYTE TRANSKETOLASE; MITOCHONDRIAL DNA; PYRUVATE DECARBOXYLASE; RAPAMYCIN; THIAMINE; TRANSKETOLASE; UNCLASSIFIED DRUG;

ACHIEVEMENT; AEROBIC METABOLISM; AUTOSOMAL RECESSIVE INHERITANCE; DEMYELINATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXTRACHROMOSOMAL INHERITANCE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LEIGH DISEASE; MEDICAL PRACTICE; NEUROPATHOLOGY; NONHUMAN; NOTE; PRIORITY JOURNAL; VITAMIN METABOLISM; HISTORY; UNITED KINGDOM; WAR;

HISTORY, 20TH CENTURY; HUMANS; LEIGH DISEASE; LONDON; WORLD WAR II;

EID: 84925669077     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304601     Document Type: Note

References (11)

1. Leigh D. Subacute necrotising encephalopathy in an infant. J Neurol Neurosurg Psychiatry 1951;14:216-21.
2. DiMauro S, Schon EA, Carelli V, et al. The clinical maze of mitochondrial neurology. Nat Rev Neurol 2013;9:429-44.
3. Tabarki B, Al-Shafi S, Al-Shahwan S, et al. Biotin-responsive basal ganglia disease revisited: clinical radiologic, and genetic findings. Neurology 2013;80:261-7.
4. Cavanagh JB, Harding BN. Pathogenic factors underlying the lesions in Leigh's disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 1994;117:1357-76.
5. Cavanagh JB. Alfred Meyer. Neuropathol Appl Neurobiol 1991;17:83-7.
6. Darin N, Oldfors A, Moslemi AR, et al. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 2001;49:377-83.
7. McBurney A, Leigh D, McIlwain H. Erythrocyte transketolase activity in suspected cases of Leigh's disease, or subacute necrotising encephalomyelopathy. Arch Dis Child 1980;55:789-94.
8. Baertling F, Rodenburg RJ, Schaper J, et al. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry 2014;85:257-65.
9. Taylor RW, Pyle A, Griffin H, et al. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. JAMA 2014;312:68-77.
10. Johnson SC, Yanos ME, Kayser EB, et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 2013;342:1524-8.
11. Chinnery PF, Craven L, Mitalipov S, et al. The challenges of mitochondrial replacement. PLoS Genet 2014;10:e1004315.